These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 341135)

  • 1. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and modulation of immune reactivity in human transplant recipients.
    Thomas F; Lee HM; Wolf JS; Mendez-Picon G; Thomas J
    Surgery; 1976 Apr; 79(4):408-13. PubMed ID: 769221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective monitoring and modulation of immune reactivity in allograft recipients.
    Thomas F; Lee HM; Thomas J; Mendez-Picon G
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological follow-up of 41 renal allograft recipients.
    Birkeland SA
    Scand J Urol Nephrol; 1976; (31 Suppl):3-37. PubMed ID: 792987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-rosette forming cell numbers in the blood of human renal allograft recipients.
    Kelly GE; Sheil AG
    Clin Exp Immunol; 1977 Mar; 27(3):454-63. PubMed ID: 324670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic characterization of the rejection of the allogenic transplanted kidney in pigs with and without immunosuppression].
    Werner M; Keitel R; Schürer KD; Otto U; Klötzer B; Kothe W; Sauer H; Ambrosius H
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(5):279-92. PubMed ID: 3538686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
    Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective monitoring and modulation of recipient immune reactivity to prevent rejection in early posttransplant period.
    Thomas F; Mendez-Picon G; Thomas J; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):537-41. PubMed ID: 362632
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.